vs 10,564 other HR bills in the 118th — cohort avg 68d
Summary
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Lobbying filings that explicitly cite this bill (9)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act) S. 4840/H.R. 9221 (RESTORE Patent Rights Act) Comments to USPTO on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (Docket No. PTO- P-2024-0003) S. 4875 (Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act) S. 2780 (Medication Affordability and Patent Integrity Act) Ensure free-market-based licensing terms and royalty rate settings of standard-essential patents (SEPs) Codification of 2019 Joint Policy Statement on Remedies for Standards-Essential Patents
Actions (3)
December 17, 2024
Referred to the Subcommittee on Trade.
February 29, 2024
Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Ways and Means, Rules, the Judiciary, Oversight and Accountability, Energy and Commerce, Intelligence (Permanent Select), Agriculture, Science, Space, and Technology, Natural Resources, Education and the Workforce, Armed Services, Transportation and Infrastructure, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cited source text, amounts, lobbyists, and targets
Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act) S. 4840/H.R. 9221 (RESTORE Patent Rights Act) Comments to USPTO on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (Docket No. PTO- P-2024-0003) S. 4875 (Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act) S. 2780 (Medication Affordability and Patent Integrity Act)
Client expense: Not reported · Firm income: $53,000
Cited source text, amounts, lobbyists, and targets
Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act) S. 4840/H.R. 9221 (RESTORE Patent Rights Act) Comments to USPTO on Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (Docket No. PTO- P-2024-0003) S. 4875 (Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act) S. 2780 (Medication Affordability and Patent Integrity Act)
Client expense: Not reported · Firm income: $53,000
Cited source text, amounts, lobbyists, and targets
HR 4175 / S 2003 "REPO for Ukrainians Act," all provisions. HR 7476 "Countering Communist China Act," all provisions. HR 8282 "Illegitimate Court Counteraction Act," all provisions. HR 8333 "BIOSECURE Act," all provisions. Issues pertaining to additional aid for Ukraine, provisions relating to accountability measures and impact on drawdown authority. Issues pertaining to aid to Israel. Issues pertaining to a Confronting CCP Human Rights Abusers Act (no bill number).
Client expense: $260,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
CPT: Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act (PERA)) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions H.R. 8134 (Restoring Americas Leadership in Innovation Act) Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (Docket No. PTO-C-2024-0004) Comments to USPTO on Patent Trial and Appeal Board Rules of Practice for Briefing Discretionary Denial Issues, and Rules for 325(d) Considerations, Instituting Parallel and Serial Petitions, and Termination Due to Settlement Agreement (Docket No. PTO- P-2023-0048) Leadership in Critical and Emerging Technologies (CET) Act to expedite CET patent examination S. 1956 (Invent Here, Make Here Act)
Client expense: Not reported · Firm income: $19,000
Cited source text, amounts, lobbyists, and targets
H.R. 760, Chinese Military and Surveillance Company Sanctions Act of 2023 H.R. 813, Global Investment in American Jobs Act H.R. 3136, National Critical Capabilities Defense Act of 2023 H.R. 3739/S. 2343, For Accurate Import Relief To Aid Retailers and Importers of Foreign Freights (FAIR TARIFF) Act of 2023 H.R. 3882/S. 1856, Leveling the Playing Field Act 2.0 H.R. 4307/S. 2115, Medical Supply Chain Resiliency Act H.R. 5375, Strengthening the Quad Act H.R. 5613, Sanctions Lists Harmonization Act H.R. 5614/S. 552, Haiti Economic Lift Program Extension Act of 2023 H.R. 6349, Preventing Adversaries from Developing Critical Capabilities Act H.R. 6555, CNL Update Act of 2023 H.R. 6614, Maintaining American Superiority by Improving Export Control Transparency Act H.R. 6990, Digital Trade for Development Act H.R. 7085, BIOSECURE Act H.R. 7151, Export Control Enforcement and Enhancement Act H.R. 7476, The Countering Communist China Act H.R. 7520, Protecting Americans Data from Foreign Adversaries Act of 2024 H.R. 7571/S. 3878, The Americas Act S. 686, Restricting the Emergence of Security Threats that Risk Information and Communications Technology (RESTRICT) Act S. 913, Innovation and Development in Ecuador (IDEA) Act of 2023 S.1325, Western Hemisphere Partnership Act of 2023 S.1421, Country of Origin Labeling (COOL) Online Act S.1926, United States-Uruguay Economic Partnership Act S. 2321, Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024 S. 3558, Prohibiting Foreign Access to American Genetic Information Act of 2024 Draft legislation to limit the availability of civil actions affected by Russia sanctions Draft legislation titled GUARD Act Draft legislation titled the United States Trade Leadership in the Indo-Pacific Act Draft legislation titled the U.S.-Africa Strategic Trade and Investment Partnership Act of (ASTIP) Draft legislation on comprehensive U.S.-Israel health and innovation collaboration Various issues relating to U.S.-Korea digital trade and services; Generalized System of Preferences (GSP) reauthorization; ratification of the Assignment of Receivables in International Trade Convention; reform of the World Trade Organization (WTO); reforms to export controls; implementation of the United States-Mexico-Canada trade agreement (USMCA); implementation of the American Manufacturing Competitiveness Act of 2016 (P.L.114-159); implementation of the Trade Facilitation and Trade Enforcement Act of 2015 (P.L. 114-125); implementation of the Uyghur Forced Labor Prevention Act (UFLPA) (P.L. 117-78); implementation of the Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act, (P.L. 117-167); reform of Section 232 of the Trade Expansion Act of 1962 (P.L. 87-794); reform of Section 301 of the Trade Act of 1974 (P.L. 93-618), including establishment of exclusion process; implementation of the African Growth and Opportunity Act (P.L. 106-200); International Emergency Economic Powers Act (IEEPA), Title II of (P. L. 95-223); implementation of the INFORM Consumers Act, Div. BB, Title III of (P. L. 117-328); implementation of the Inflation Reduction Act, (P.L. 117-169); implementation of the Build America, Buy America Act (BABA) statute contained in the Infrastructure Investment and Jobs Act (P.L. 117-58); Foreign Assistance Act for Fiscal Year 2024; Development of the National Defense Authorization Act for Fiscal Year 2025; reauthorization of the Customs-Trade Partnership Against Terrorism (CTPAT); pharmaceutical price controls; domain name system abuse and related IP issues; WTO Trade-Related Intellectual Property Rights (TRIPS) waiver and related forced technology transfer measures; World Health Organization (WHO) pandemic agreement; implementation of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; Office of the Intellectual Property Enforcement Coordinator and the National Intellectual Property Rights Coordination Center; patent linkage and regulatory data protection; efforts related to the reauthorization of the African Growth and Opportunity Act (AGOA) (P.L. 106-200); China's intellectual property regime industrial policies and cyber security; implementation of the U.S.- China economic and trade agreement; IP issues relating to trade secret theft; IP issues relating to internet counterfeiting and piracy; IP issues relating to artificial intelligence; implementation of U.S. sanctions on Russia including those related to Russias threats to and invasion of Ukraine; U.S. sanctions on Turkey; U.S.-EU negotiations on a legal data transfer mechanism; U.S.-EU energy and sustainability cooperation; United States-India Trade Policy Forum; EU and international tax policy including digital tax proposals; U.S.-EU Trade & Technology Council; EU-U.S. Joint Technology Competition Policy Dialogue; EU Digital Markets Act; EU Digital Services Act; EU Data Act; EU AI Act; EU Carbon Border Adjustment Mechanism; EU digital sovereignty and regulatory agenda; European Cybersecurity Certification Scheme for Cloud Services (EUCS); Global Internet Governance; Global Cross Border Privacy Rules Forum; Digital-related policies in the G20, G7, OECD, and other international fora; Indias Information Communications Technology (ICT) Tariffs; Federal Trade Commission statutory authority under Section 19 of the Federal Trade Commission Act of 1914; efforts to modernize the Committee on Foreign Investment in the United States (CFIUS); efforts related to the 2024 Farm Bill; efforts related to opposing international imposition of digital services taxes; related efforts supporting strong digital trade rules; efforts related to the negotiation of the U.S. - EU Arrangements on Global Steel and Aluminum Excess Capacity and Carbon Intensity; efforts to modify permanent normal trade relations treatment with China & Kazakhstan; U.S. economic and commercial relations with key trading partners across the globe; efforts to draft and implement an outbound investment screening mechanism; efforts related to establishing a domestic carbon border tax mechanism, foreign pollution fees; efforts related to modernizing customs processes and updating tariff application procedures including revisions to the de minimus statute; efforts to revise country of origin labeling requirements for animal and online products; efforts related to boosting trade relations with the Latin American region; efforts related to electric vehicle tax credit incentives in the Inflation Reduction Act (P.L. 117-169); efforts related to the development and negotiation of the Indo-Pacific Economic Framework (IPEF); efforts related to the development and negotiation of the U.S.-Taiwan Initiative on 21st Century Trade; efforts related to the development and negotiation of the Americas Partnership for Economic Prosperity (APEP); efforts related to the development and negotiation of the U.S.-UK Dialogue on the Future of Atlantic Trade; efforts related to the development and negotiation of the U.S.-Kenya Strategic Trade and Investment Partnership; efforts to significantly revise U.S. antidumping and countervailing duty law; efforts to provide financial support, trade facilitation, and infrastructure support to the African Continental Free Trade Area (AfCFTA); implementation and enforcement of U.S. free-trade agreements in force with Canada and Mexico (the United States-Mexico-Canada Agreement), the Dominican Republic-Central America Free Trade Agreement (CAFTA-DR FTA), Colombia and South Korea; Implementation and enforcement of the agreements and ongoing negotiations of the World Trade Organization (WTO); efforts related to the Export-Import Bank (Ex-Im Bank); trade policy consideration with regard to cross-border data flows and issues of forced localization, and forced disclosure of source code; tax treaties with Poland and Croatia; international trade and regulatory practices impacting digital goods and services; international competition policy and related regulations; international artificial intelligence policy; international 5G policy and telecommunications infrastructure; international cybersecurity policy; international policy on standards development; international policies related to content moderation and intermediary liability; advancing international regulatory cooperation; steel and aluminum tariffs; trade policy concerns regarding customs duties on electronic transmissions; trade negotiations and trade priorities between the U.S. and the European Union; trade negotiations and trade priorities between the U.S. and the United Kingdom; trade negotiations and trade priorities between the U.S. and Japan; trade negotiations and trade priorities between the U.S. and China; U.S.-Brazil trade; Pacific Digital Trade Agreements; U.S. Chile Tax Treaty, Convention for the Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income and Capital; U.S. Trade Representative section 301 investigation of Frances digital services tax; efforts to pass the Miscellaneous Tariff bill; Trade Promotion Authority (TPA) reauthorization and reform; Russian sovereign debt; Commercial Service Office in Bangladesh; Indo-Pacific Economic Framework and associated issues, digital trade de minimus level for duty free clearance of low value goods, competition provisions; patent examination practices and patent quality measures; tech transfer frameworks under the Bayh-Dole Act (P.L. 96-517); recommendations for Export Controls Cooperation at the U.S.-EU Trade and Technology Council; adoption of digital clothing labels; international competition policy, specifically FTC and DOJ involvement in the European Unions implementation of the EU Digital Markets Act; compliance with sanctions on the Russian Federation and potential legal penalties in Russian courts for U.S. companies; proposal for General License Authorizing Private Commercial Arbitration Proceedings Involving Blocked Persons; The United States Trade Representatives decision to withdraw support for digital trade in the context of World Trade Organizations e-commerce negotiations; supply chain and defense industrial base issues; printed circuit boards; customs modernization legislation; legislation to alter de minimus policies
Cited source text, amounts, lobbyists, and targets
H. J. Res. 96, Compact of Free Association Amendments Act of 2023, all provisions. H. Res. 1107, Expressing the sense of Congress that Israel must be in full support of any negotiation or agreement relating to the Israeli-Hamas conflict, including a two-state solution or similar long-term plan relating to Israel and Palestinians for it to move forward, all provisions. H. Res. 966, Condemning rape and sexual violence committed by Hamas in its war against Israel, all provisions. H.R. 280, Foreign Adversary Communications Transparency Act, all provisions. H.R. 2864, Countering CCP Drones Act, all provisions. H.R. 2882, Further Consolidated Appropriations Act, 2024, (issues related to U.S. contributions to international organizations, beneficial ownership, and Compacts of Free Association). H.R. 3016, IGO Anti-Boycott Act, all provisions. H.R. 3202, Assad Regime Anti-Normalization Act of 2023, all provisions. H.R. 3266, Peace and Tolerance in Palestinian Education Act, all provisions. H.R. 3334, STOP CCP Act, all provisions. H.R. 3774, Stop Harboring Iranian Petroleum (SHIP) Act, all provisions. H.R. 4175, REPO for Ukrainians Act, all provisions. H.R. 4564, Countering Hate Against Israel by Federal Contractors Act, all provisions. H.R. 4660, HALT Our Adversaries Act, all provisions. H.R. 4723, Upholding the Dayton Peace Agreement Through Sanctions Act, all provisions. H.R. 5917, Strengthening Tools to Counter the Use of Human Shields Act, all provisions. H.R. 5933, Defending Education Transparency and Ending Rogue Regimes Engaging in Nefarious Transactions (DETERRENT) Act, all provisions. H.R. 6045, Standing Against Houthi Aggression Act, all provisions. H.R. 6831, VERDAD Reauthorization Act, all provisions. H.R. 7202, Uncovering UNRWAs Terrorist Crimes Act, all provisions. H.R. 7256, U.S.-South Africa Bilateral Relations Review Act, all provisions. H.R. 7478, PROTECT Jewish Student and Faculty Act, all provisions. H.R. 7633, Enhance Cooperation Against Terrorism Act, all provisions. H.R. 7914, Accountability for Terrorist Perpetrators of October 7th Act, all provisions. H.R. 8001, Combating Houthi Threats and Aggression Act, all provisions. H.R. 8011, Iranian Terror Prevention Act, all provisions. S. 1829, Stop Harboring Iranian Petroleum (SHIP) Act, all provisions. S. 2003, REPO for Ukrainians Act, all provisions. S. 3174, Stop Support for Hamas Act of 2023, all provisions. S. 3717, Preventing Terrorism at the U.N. Act of 2024, all provisions. S. 3874, Hamas and Palestinian Islamic Jihad International Terrorism Support Prevention Act of 2024, all provisions. S. 3989, CCP Lobbying Divestment Act, all provisions. S. Res 617, A resolution expressing the sense of the Senate that Israel has the inherent right to defend itself and take necessary steps to eradicate the terrorist threat posed by Hamas, all provisions. S. Res. 504, A resolution requesting information on Israel's human rights practices pursuant to section 502B(c) of the Foreign Assistance Act of 1961, all provisions. H.R. 7476, Countering Communist China Act, (issues related to Chinese EV Manufacturing; Chinese Influence in U.S. Higher education; Compacts of Free Association Amendments Act; Countering Atrocities through Currency Accountability Act; DATA Act; Protecting Americans Retirement Savings Act (PARSA); Sanctioning Supporters of Slave Labor Act; Sanctions on Communist Chinese Military and Surveillance Companies;STOP CCP Act; U.S. China Sanctions Policy; and U.S. Contributions to International Organizations). Issues related to Al Jazeera FARA Registration; Antisemitism in Latin America; Boycotts Against Israel; Chinas Belt and Road Initiative; Chinese and Qatari Influence in U.S. Higher Education; Chinese Global Infrastructure; Chinese Investment in Mexico; Chinese, Iranian, and Russian Activities in Latin America; Congressional Oversight of U.S. Foreign Policy and Aid; DFC Reauthorization; Egypts Role in the Israel-Hamas War; Implementation of Sanctions on West Bank Persons in Executive Order 14115; Exposing Hamas War Crimes; Extradition of Hamas Leaders; Foreign Influence and Information Operations; Genocide Incitement Prohibitions; Hamas Violence Against Women; Implementation of the Taylor Force Act; Information Operations Sanctions; International Committee of the Red Cross Accountability; Iranian Malign Activities in Iraq and Syria; Iran-South Africa Relations; Israel-Latin America Relations; Normalization in the Middle East and Africa; Oversight of DEA Specially-Vetted Units Oversight; Palestinian Financing, Politics, and Terrorism; Sub-Saharan Africa Terror Finance; Support for U.S. Ally Israel at International Organizations; Support for U.S. Ally Israel on College Campuses; Turkey and Qatars Support of Terrorism; U.S. Afghanistan Sanctions Policy; U.S. Anti-Corruption Sanctions and Strategy; U.S. China Sanctions Policy; U.S. Contributions to International Organizations; U.S. Hamas Sanctions Policy; U.S. Hezbollah Sanctions Policy; U.S. Hostage Policy; U.S. Iran Sanctions Policy; U.S. Israel-Hamas War Policy; U.S. North Korea Sanctions Policy; U.S. Pacific Islands Strategy; U.S. Policy on Chinas Human Rights Abuses; U.S. Policy on Irans Human Rights Abuses; U.S. Policy on Irans Support for Terrorism; U.S. Policy on UNRWA Reform; U.S. Russia Sanctions Policy; U.S. Strategic Objectives in Latin America; U.S. Syria Sanctions Policy; U.S. Venezuela Sanctions Policy; and U.S.-Mexico Relations (no bill).
Cited source text, amounts, lobbyists, and targets
Issues pertaining to the nomination of Jack Lew as Ambassador of the United States to Israel. HR 7476 "Countering Communist China Act," all provisions. HR 7521 "Protecting Americans from Foreign Adversary Controlled Applications Act," all provisions.
Client expense: $190,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
P Patent Trial and Appeal Board, including institution of proceedings, Fintiv/NHK and related procedures Patent-eligible subject matter Injunctive relief against patent infringers Standard Essential Royalty Act, to establish a patent licensing royalty rate-setting judicial panel disadvantageous to patent owners and favorable to patent infringers H.R. 3535 (Advancing Americas Interest Act) to disadvantageously change U.S. firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods S. 2321/H.R. 5893 (Commerce-Justice-Science Appropriations, FY24) report language to erect barriers to Sec. 337 USITC remedies to block importation of U.S. patent-infringing goods Proposals to misuse Bayh-Dole Acts march-in against patent ownership rights based on product price Unilateral changes to Dept. of Energy funding agreements requiring headquarters review of any licensing agreement, undermining the Bayh-Dole Act Comments on Initiatives to Ensure the Robustness and Reliability of Patent Rights (Docket No. PTO-P-2022-0025) Request for Comments Regarding Joint USPTO-FDA Collaboration Initiatives (Docket No. PTO-P-2022-0037) Federal position on proposal at World Trade Organization to waive intellectual property protections due under Trade-Related Aspects of Intellectual Property Rights Agreement with regard to COVID-19-related inventions Comments on U.S. International Trade Commission Investigation No. 332-596, COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities Comments on advance notice of proposed rulemaking, Changes Under Consideration to Discretionary Institution Practices, Petition Word-Count Limits, and Settlement Practices for America Invents Act Trial Proceedings Before the Patent Trial and Appeal Board (Docket No. PTO-P-2020-0022) S. 2220/H.R. 4370 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) Comments related to National Institutes of Health, Workshop on Transforming Discoveries into Products: Maximizing NIHs Levers to Catalyze Technology Transfer S. 2140 (Patent Eligibility Restoration Act) Mandatory customer stay that deprives patent owners of the ability to enforce their patent rights against all parties such as through injunctive relief and that would unfairly protect direct and contributory patent infringers, including large retail corporations Defending American Patents Act, which would punish U.S. patent owners with the loss of six years of patent protection for asserting their patent in a foreign court against an American patent infringer H.R. 5475 (Preventing Adversarial Patents Act), which would radically change from the hallmark of merit-based U.S. patent issuance, by adding denial or unenforceability of patents based on certain characteristics of the patentee Comments on U.S. Patent & Trademark Office, Joint Collaboration Initiative Regarding Standards (Docket No. PTO-C-2023-0034) Digital copyright piracy, site-blocking injunction National Institute of Standards and Technology, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights (Docket No. NIST-2023-0008) Comments to U.S. Patent & Trademark Office, regarding WIPO IGC Negotiations on Genetic Resources and Associated Traditional Knowledge (Docket No.: PTO-C-2023-0019) H.R. 7476 (Countering Communist China Act) intellectual property provisions
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR)
Client expense: $160,000 · Firm income: Not reported